New VC Funds Raise $33B in 2026: Map for Founders

Twenty newly launched venture funds have collectively raised more than $33 billion in 2026, a figure that lands with real weight given how cautious limited partners have been since the 2022 correction. This is not a trailing indicator. Funds that have already closed are, by definition, in deployment mode, meaning the partners running them are actively hunting deals, not still on roadshows. For founders who have spent the last two years hearing "we're being selective," this map of fresh capital is the most actionable signal the market has produced all year.

The concentration of this capital tells its own story. According to PitchBook-NVCA data, just six managers, including Andreessen Horowitz, Thrive Capital, and Founders Fund, captured 76.2% of Q1 2026's total venture capital raised, or $36.4 billion between them. That lopsided distribution means the remaining funds, the twenty newer and often more focused vehicles tracked here, collectively account for a smaller but strategically distinct slice of the market. These are managers with mandates to move fast and build portfolios from scratch, which changes the pitch dynamic entirely.

Three sectors are absorbing the bulk of the new dry powder: AI, biotech, and defense. The pattern is consistent across geographies. European Q1 fund launches, tracked by Vestbee, pointed to a "clear reallocation of capital toward deeptech, climate, and defence, sectors increasingly aligned with Europe's industrial and geopolitical priorities." Notable funds in the cohort include Medicxi, United Founders, and Pitango, with the Nordics and Israel drawing renewed LP interest after a quieter 2024. Founders operating in these verticals are not just well-positioned, they are fishing in a stocked pond.

The broader implication is a structural shift in how deal volume will move through the rest of the year. Venture funds operate under pressure to deploy within defined windows, typically three to four years from close. Funds that closed in Q1 and Q2 of 2026 are now on the clock. That internal urgency does not make partners reckless, but it does make them responsive. Founders who approach the right managers with tight decks and clear traction metrics will find fewer gatekeeping delays than they would have encountered twelve months ago.

The next twelve months will likely see deal volume accelerate, particularly at the early and growth stages, as these freshly capitalized funds compete to source the best companies before their peers do. Sectors that have already attracted multiple new fund mandates, AI infrastructure, defense tech, and climate biotech, will see valuation pressure tick upward as competition for the top deals intensifies. Founders who move now, before the crowd catches on to exactly where the capital is sitting, hold a timing advantage that will not last long.